000 | 02110cam a2200349 a 4500 | ||
---|---|---|---|
003 | EG-GiCUC | ||
005 | 20250223031118.0 | ||
008 | 141208s2014 ua h f m 000 0 eng d | ||
040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
041 | 0 | _aeng | |
049 | _aDeposite | ||
097 | _aPh.D | ||
099 | _aCai01.11.27.Ph.D.2014.Ra.G | ||
100 | 0 | _aRasha Ramadan Mostafa | |
245 | 1 | 0 |
_aGalectin-3 expression in colorectal carcinoma : _bImmunohistochemical and histopathological study / _cRasha Ramadan Mostafa ; Supervised Badawia Bayoumi Ibrahim , Dina Omar Helmy , Samar Abdelmonem Elsheikh |
246 | 1 | 5 |
_aالتعبير عن جلاكتين-3 فى سرطان القولون و المستقيم : _bدراسة كيميائية نسيجية هستومناعية و هستوباثولوجية |
260 |
_aCairo : _bRasha Ramadan Mostafa , _c2014 |
||
300 |
_a194 P. : _bfacsimiles ; _c25cm |
||
502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Pathology | ||
520 | _aColorectal cancer is one of the leading causes of cancer death in both developed and developing nations. It is the third most common type of cancer worldwide. Evaluation of the immunohistochemical expression of galectin-3 in cases of colorectal carcinoma and correlation between galectin-3 expression and other clinical and pathological features. The current study included sixty cases of colorectal carcinomas collected from the pathology department, Faculty of Medicine, Cairo University during the period from January 2011 till March 2013, studied histologically and immunohistochemically for galectin-3 expression. -Galectin-3 expression was positive in 81.7% of total colorectal carcinoma studied cases | ||
530 | _aIssued also as CD | ||
653 | 4 | _aColorectal carcinoma | |
653 | 4 | _aGalectin-3 | |
653 | 4 | _aPathology | |
700 | 0 |
_aBadawia Bayoumi Ibrahim , _eSupervisor |
|
700 | 0 |
_aDina Omar Helmy , _eSupervisor |
|
700 | 0 |
_aSamar Abdelmonem Elsheikh , _eSupervisor |
|
856 | _uhttp://172.23.153.220/th.pdf | ||
905 |
_aNazla _eRevisor |
||
905 |
_aSamia _eCataloger |
||
942 |
_2ddc _cTH |
||
999 |
_c48651 _d48651 |